Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Medicare Advantage

Stocks Recover on Strength in Health Insurers and Energy Stocks

The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.30%. March E-mini S&P futures (ESH25 ) are up +0.26%, and March E-mini Nasdaq futures...

Barchart

Stocks Slide and Bond Yields Rise as Fed Rate Cut Hopes Dwindle

The S&P 500 Index ($SPX ) (SPY ) today is down -0.35%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.75%. March E-mini S&P futures (ESH25 ) are down -0.42%, and March E-mini Nasdaq futures...

Barchart

Stocks Pressured by Rising Bond Yields as Fed Rate Cut Hopes Fade

The S&P 500 Index ($SPX ) (SPY ) today is down -0.71%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.21%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.15%. March E-mini S&P futures (ESH25 ) are down -0.66%, and March E-mini Nasdaq futures...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Watch Out for the ‘Medigap Trap’

The Medigap trap can snag those who chose Medicare Advantage and plan to switch to traditional Medicare later as their needs change.

Kiplinger

How Cigna Remains at the Top of the Health Insurance Food Chain

The Cigna Group has been agile and nimbly navigating the trends in managed care as it unloaded its Medicare Advantage business before the storm hit its peers.

MarketBeat

Humana's Quarterly Earnings Preview: What You Need to Know

Humana is set to release its fourth-quarter results later this month, with analysts anticipating a significant drop in earnings.

Barchart

Problems with Medicare Advantage Plans Keep Mounting

Complaints about Medicare Advantage include denial of service and slow care approvals.

Kiplinger

Read news from The Economist, FT, and more,
with one subscription

US lawmakers eye health insurance reform as frustrations mount

Nearly one in four doctors say the practice of prior authorization has led to serious issues for patients

The Guardian - US

The pros and cons of Medicare Advantage plans

Advice to help you choose between Original Medicare and Medicare Advantage plans.

Fortune

What does Medicare Part B cover? Here’s everything you need to know about its benefits and costs

Part B has the widest array of health benefits—and the widest array of coverage exclusions.

Fortune

Dr. Oz turbocharges Medicare Advantage and everyone monitors their glucose: 10 health care predictions for 2025 from top investors

Although Trump is entering the White House with an electoral mandate, he will not spend any political capital on health care legislation.

Fortune

Six Year-End Deadlines for Retirees in 2024

Here are six key end-of-year 2024 deadlines that retirees and those saving to retire won't want to miss.

Kiplinger

US trails developed democracies in healthcare costs for older adults

Report comparing 10 peer countries shows how holes in Medicare coverage lead to Americans skipping care

The Guardian - US

Nursing home staffing rule in limbo as Trump 2.0 approaches - Roll Call

A Biden rule aimed at providing ample staffing for nursing homes may be rolled back either by Republicans in the lame duck or by Trump.

Roll Call

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Undervalued Healthcare Stocks With Upside Potential

The healthcare industry thrives due to novel drug pipeline discoveries, AI integration to streamline processes and technological advancements. So, investing in undervalued healthcare stocks with upside potential, Pfizer (PFE), Cigna Group (CI), and Centene Corp (CNC), could be a wise idea. Keep reading….

Fortune

Medicare agents might not recommend the best plans this year as profits take priority

Curbing agents’ commissions may hurt beneficiaries.

Salon

Dr. Oz's finanical conflicts of interest

Oz’s holdings, some shared with family, included a stake in UnitedHealth Group worth as much as $600,000

USA Today Sports Media Group

Learn About Medicare Advantage Plan Updates for 2025

Medicare Advantage plans are evolving, and 2025 is shaping up to bring significant improvements and opportunities for enrollees. But what exactly is changing? What updates should you know about to make informed decisions regarding your healthcare? ...

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Taxpayers spend 22% more per patient to support Medicare Advantage – the private alternative to Medicare that promised to cost less

Medicare Advantage – the commercial alternative to traditional Medicare – is drawing down federal health care funds, costing taxpayers an extra 22% per enrollee to the tune of US$83 billion a year.

Investors Business Daily

UnitedHealth Rises On Medicare Star Ratings Ruling; Humana Rallies

UnitedHealth rose after a federal judge ordered a rerating of the Dow Jones giant's Medicare Star Ratings.

Fortune

How Dr. Oz could change Medicare under President Trump

What you might expect from Oz if he runs Medicare, Medicaid, and management of the Affordable Care Act at the 6,000-person CMS.

Fortune

A glimpse into possibly health policy under Trump, including abortion-pill and gender-transition crackdowns

Donald Trump's Agenda 47 and the Heritage Foundation's Project 2025 provide plenty of clues into what health-care changes may be coming.

Fortune

Shopping for a 2025 Medigap policy? There may be some good news for you

A Biden administration proposed rule, scheduled to take effect January 1, 2025, could guarantee Medigap coverage regardless of health conditions.

Kiplinger

What You Will Pay for Medicare in 2025

Medicare premiums for 2025, and the cost of Medicare Part A, Medicare Part B and Part D premiums and deductibles, have gone up. Here is how much you'll pay in 2025.

Kiplinger

Medicare Drug Plans Are Getting Better Next Year. Some Will Also Cost More.

Upcoming changes to the Part D drug benefit, including a $2,000 cap on out-of-pocket medication, will benefit millions of Americans. But higher premiums may also be on the way

1 2 3 4 5

People

Chiquita BrooksLaSure

14 stories

Jeffrey Singer

12 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.